Journal of Intellectual Property Law & Practice, Seroquel case, by Darren Smyth

No items found.
22 June 2012
Tags
Life

The Journal of Intellectual Property Law and Practice (vol. 7, issue 7) has published an article by partner Darren Smyth about a case in the UK Patents Court about AstraZeneca’s patent for its drug quetiapine, marketed as Seroquel.

AstraZeneca's European patent EP 0907364 relating to a sustained release formulation of the antipsychotic drug quetiapine was held invalid in the UK, this being the opposite outcome to parallel litigation before the District Court of the Hague.

To read the JIPLP article in full, click here.

Related articles

EIP welcomes Anders Hansson as Partner to further strengthen our digital practice
19 January 2026
EIP is pleased to welcome Anders Hansson as Partner, bringing nearly 20 years of experience in AI, robotics, digital technologies, and European patent strategy. His industry and private‑practice background further strengthens our digital and high‑tech capabilities across Europe.
EIP Launches Tech & AI Function to Drive Innovation and Client Excellence
06 November 2025
When it comes to technology, EIP has always been ahead of the curve; we are proud to announce the evolution of our IT department into a dedicated Tech & AI function, marking a bold step towards...
Trade Secrets: Navigating geopolitical risks and IP theft in the semiconductor industry
04 November 2025
Semiconductors have always been a critical technology but have grown significantly in strategic importance in recent years. They have become the key building block in developing and existing markets, including quantum computing, edge computing, AI, IoT, automotive, cellular data technology, smartphones, robotics, and many more. The complex designs and innovations that power semiconductor manufacturing are invaluable both to the world’s economy and technological advancement. Consequently, the semiconductor industry has found itself at the centre of geopolitical tensions, especially between the United States and China. It has become a prime target for cyberattacks and intellectual-property (IP) theft. As such, companies operating in this area must be more vigilant in protecting their intellectual assets.